Moody's Investors Service revised Columbia, Md.-based MedStar Health's outlook to stable from positive.
The outlook revision reflects Moody's Investors Service's expectation that MedStar's operations will remain pressured over the coming years.
Moody's also affirmed the "A2" rating on MedStar's bonds. The rating affirmation is based on numerous factors, including MedStar's diversified clinical delivery network, strengthening market position and consistently profitable operations.